Early studies have reported various electrolyte abnormalities in patients who progress to the severe form of COVID-19. It has also been shown that pre-existent chronic kidney disease increases the risk of more severe COVID-19 complications. This webinar will discuss COVID-19 critical illness and its impact on electrolyte homeostasis and kidney function. We will describe the common electrolyte abnormalities, their pathophysiology and treatment recommendations. We will also describe the common finding of acute kidney injury (AKI) in COVID-19, its pathophysiology, and strategies to manage it in the acute care setting. A rapid blood analyzer for monitoring electrolytes, kidney function, blood gases and metabolites in acute care settings will be described.

Intended Audience

  • Critical care clinicians

Learning Objectives

  • Understand the prognostic significance of electrolyte abnormalities in COVID-19
  • Identify key electrolyte abnormalities in advanced COVID-19 illness and recommendations for
  • monitoring and treatment
  • Understand frequency and pathophysiology of acute kidney injury in COVID-19 illness
  • Identify strategies to manage AKI in an acute care setting

Educational Credits

  • This program has been approved by the American Association of Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 23381. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned.


Dennis Begos, MD, FACS, FACRS

Dennis Begos, MD, FACS, FACRS
Associate Medical Director, Medical and Scientific Affairs
Nova Biomedical